Crescent Biopharma Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Josh Brumm
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Josh Brumm (47 yo)
Mr. Joshua T. Brumm, also known as Josh, is Chief Executive Officer & Director of Crescent Biopharma, Inc. from March 2025. He is Chairman of Amphista Therapeutics Limited. He is Director of AIRNA Corporat...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | no data | no data | |
| President & COO | less than a year | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior VP of Finance | less than a year | no data | no data | |
| Chief Scientific Officer | less than a year | no data | no data | |
| General Counsel & Corporate Secretary | less than a year | no data | no data | |
| Chief Communications Officer | less than a year | no data | no data | |
| Chief Business Officer | 1yr | no data | 0.20% $ 493.9k | |
| Senior Vice President of Technical Operations | less than a year | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Executive VP and Chief of Strategy & Operations | less than a year | no data | no data |
Experienced Management: CBIO's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Director | 1yr | no data | 0.36% $ 869.6k | |
| Independent Chairman | 1.1yrs | no data | no data | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | less than a year | no data | 0% $ 0 |
Experienced Board: CBIO's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/31 07:05 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Crescent Biopharma, Inc. is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Schmidt | Cantor Fitzgerald & Co. |
| Mitchell Kapoor | H.C. Wainwright & Co. |
| Akash Tewari | Jefferies LLC |